

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.04366756 |
| 2 | cellular response to type I interferon (GO:0071357) | 6.61180626 |
| 3 | type I interferon signaling pathway (GO:0060337) | 6.61180626 |
| 4 | response to type I interferon (GO:0034340) | 6.57066934 |
| 5 | positive regulation of interferon-alpha production (GO:0032727) | 5.96671185 |
| 6 | response to interferon-alpha (GO:0035455) | 5.76790219 |
| 7 | regulation of interferon-alpha production (GO:0032647) | 5.62061738 |
| 8 | cellular response to interferon-beta (GO:0035458) | 5.42895352 |
| 9 | response to interferon-beta (GO:0035456) | 5.41543994 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 5.00618818 |
| 11 | cellular response to interferon-alpha (GO:0035457) | 4.91706954 |
| 12 | cellular response to exogenous dsRNA (GO:0071360) | 4.86367840 |
| 13 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.83007567 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.71627268 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.71627268 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.66431624 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.66431624 |
| 18 | negative regulation of viral genome replication (GO:0045071) | 4.61140502 |
| 19 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.47137761 |
| 20 | response to peptidoglycan (GO:0032494) | 4.39997364 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.37239859 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.37103199 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.23304055 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 4.19815173 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 4.19815173 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.19815173 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.19815173 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.19815173 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 4.19815173 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.05293283 |
| 31 | positive regulation of interferon-beta production (GO:0032728) | 4.04215213 |
| 32 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.03931855 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 4.03035411 |
| 34 | cellular response to virus (GO:0098586) | 3.98098667 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.96858172 |
| 36 | regulation of RIG-I signaling pathway (GO:0039535) | 3.95100224 |
| 37 | B cell mediated immunity (GO:0019724) | 3.92166182 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.85771435 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.79968222 |
| 40 | detection of other organism (GO:0098543) | 3.78028001 |
| 41 | detection of bacterium (GO:0016045) | 3.70232584 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.70087250 |
| 43 | microglial cell activation (GO:0001774) | 3.60555561 |
| 44 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.60000431 |
| 45 | defense response to protozoan (GO:0042832) | 3.59587312 |
| 46 | respiratory burst (GO:0045730) | 3.57293111 |
| 47 | T cell migration (GO:0072678) | 3.56809591 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.51850708 |
| 49 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.43350469 |
| 50 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.42732519 |
| 51 | positive regulation of type 2 immune response (GO:0002830) | 3.41487936 |
| 52 | cellular response to interferon-gamma (GO:0071346) | 3.38424112 |
| 53 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.38356314 |
| 54 | defense response to virus (GO:0051607) | 3.38036469 |
| 55 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.35825354 |
| 56 | response to exogenous dsRNA (GO:0043330) | 3.35798208 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.35655485 |
| 58 | response to host immune response (GO:0052572) | 3.35655485 |
| 59 | macrophage activation (GO:0042116) | 3.33500054 |
| 60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32666420 |
| 61 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.32411040 |
| 62 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.32327164 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 3.32213970 |
| 64 | T-helper 1 type immune response (GO:0042088) | 3.29965907 |
| 65 | regulation of chemokine biosynthetic process (GO:0045073) | 3.29522787 |
| 66 | leukocyte aggregation (GO:0070486) | 3.27156981 |
| 67 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.26850044 |
| 68 | interferon-gamma secretion (GO:0072643) | 3.26671045 |
| 69 | response to protozoan (GO:0001562) | 3.23179816 |
| 70 | regulation of gamma-delta T cell activation (GO:0046643) | 3.22911046 |
| 71 | detection of biotic stimulus (GO:0009595) | 3.20270494 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19743240 |
| 73 | positive regulation of defense response to virus by host (GO:0002230) | 3.19343046 |
| 74 | NIK/NF-kappaB signaling (GO:0038061) | 3.18444511 |
| 75 | regulation of T cell tolerance induction (GO:0002664) | 3.12335384 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12089888 |
| 77 | regulation of response to interferon-gamma (GO:0060330) | 3.11930901 |
| 78 | response to interferon-gamma (GO:0034341) | 3.11332788 |
| 79 | lymphocyte chemotaxis (GO:0048247) | 3.10075997 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 3.10048624 |
| 81 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.09211548 |
| 82 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.08893981 |
| 83 | cellular response to zinc ion (GO:0071294) | 3.08315550 |
| 84 | regulation of defense response to virus by host (GO:0050691) | 3.07595737 |
| 85 | positive regulation of interleukin-17 production (GO:0032740) | 3.06330354 |
| 86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04597317 |
| 87 | macrophage activation involved in immune response (GO:0002281) | 3.04391399 |
| 88 | regulation of interleukin-17 production (GO:0032660) | 3.04033843 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03332282 |
| 90 | negative regulation of interleukin-17 production (GO:0032700) | 3.02921187 |
| 91 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.02633970 |
| 92 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01859057 |
| 93 | granulocyte activation (GO:0036230) | 3.01789902 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01458374 |
| 95 | negative regulation of innate immune response (GO:0045824) | 3.01209823 |
| 96 | negative regulation of T cell mediated immunity (GO:0002710) | 3.00996491 |
| 97 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.00869156 |
| 98 | mast cell activation (GO:0045576) | 3.00035807 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.99590821 |
| 100 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99532113 |
| 101 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.98350463 |
| 102 | myeloid cell activation involved in immune response (GO:0002275) | 2.97852397 |
| 103 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95087579 |
| 104 | response to host (GO:0075136) | 2.95087579 |
| 105 | response to host defenses (GO:0052200) | 2.95087579 |
| 106 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.94069161 |
| 107 | neutrophil activation (GO:0042119) | 2.93970751 |
| 108 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.90785633 |
| 109 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.89398366 |
| 110 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.89243118 |
| 111 | response to muramyl dipeptide (GO:0032495) | 2.89239904 |
| 112 | regulation of type 2 immune response (GO:0002828) | 2.88939204 |
| 113 | regulation of tolerance induction (GO:0002643) | 2.88430261 |
| 114 | positive regulation of interleukin-12 production (GO:0032735) | 2.87069074 |
| 115 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.86889574 |
| 116 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.86581380 |
| 117 | regulation of activation of Janus kinase activity (GO:0010533) | 2.85852235 |
| 118 | cellular extravasation (GO:0045123) | 2.85337678 |
| 119 | negative regulation of viral process (GO:0048525) | 2.84977058 |
| 120 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.84672306 |
| 121 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.84587642 |
| 122 | regulation of interferon-beta production (GO:0032648) | 2.84319590 |
| 123 | germinal center formation (GO:0002467) | 2.84281725 |
| 124 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83560577 |
| 125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83298042 |
| 126 | positive regulation of isotype switching (GO:0045830) | 2.83272520 |
| 127 | interferon-gamma production (GO:0032609) | 2.82347706 |
| 128 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.81961355 |
| 129 | regulation of growth of symbiont in host (GO:0044126) | 2.81961355 |
| 130 | negative regulation of growth of symbiont in host (GO:0044130) | 2.81961355 |
| 131 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.81961355 |
| 132 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81501305 |
| 133 | positive regulation of lymphocyte migration (GO:2000403) | 2.78269634 |
| 134 | regulation of chronic inflammatory response (GO:0002676) | 2.77801220 |
| 135 | myeloid dendritic cell differentiation (GO:0043011) | 2.77455960 |
| 136 | cellular response to interleukin-15 (GO:0071350) | 2.76892116 |
| 137 | regulation of viral genome replication (GO:0045069) | 2.76493958 |
| 138 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.76402671 |
| 139 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.74980410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.20062370 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.56347142 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.11750735 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.58619536 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.21119416 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.68076704 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72242273 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.34340585 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28549225 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.28423275 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.24166413 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20640349 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.02022126 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.99706119 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.73591860 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.56056987 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.29244765 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.29029343 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21624858 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.08523758 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07007171 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02180976 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96316133 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94033325 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80950122 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77494676 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.77417348 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.76102877 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75864890 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63335508 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62869766 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.61849655 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60674913 |
| 34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58148292 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54714415 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53021459 |
| 37 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52267733 |
| 38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.51609396 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50288128 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47938192 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39350109 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37539740 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36051260 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35965494 |
| 45 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30599398 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30484906 |
| 47 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29859022 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25763649 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25414923 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25080361 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23740937 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22780412 |
| 53 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22321259 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20424816 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19144889 |
| 56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18875025 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17061006 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15428758 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14234589 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13730552 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07447219 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06108777 |
| 63 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04882643 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04680371 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.02704243 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00670998 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00356626 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 0.98433252 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97545731 |
| 70 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96796787 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96740868 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96284562 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95526159 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92754128 |
| 75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92608699 |
| 76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92405116 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91436216 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91308457 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90168810 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89781421 |
| 81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89405130 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89005896 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88960257 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88415696 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86879815 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85563788 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85175413 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81385868 |
| 89 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.79488726 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.78808478 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.77243125 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.76940768 |
| 93 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.76434843 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.76124056 |
| 95 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75446342 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74637217 |
| 97 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.74603508 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74551656 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74544152 |
| 100 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.73876612 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73554556 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72832852 |
| 103 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.71734304 |
| 104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71310739 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70794188 |
| 106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.70783648 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70734802 |
| 108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.70095200 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.69437048 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.66010146 |
| 111 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.64864245 |
| 112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63240242 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.61578716 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.61132247 |
| 115 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58263112 |
| 116 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.56737624 |
| 117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.55243447 |
| 118 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.52733553 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52050980 |
| 120 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.50005889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.03106560 |
| 2 | MP0009785_altered_susceptibility_to | 4.71847177 |
| 3 | MP0003724_increased_susceptibility_to | 4.42495139 |
| 4 | MP0006082_CNS_inflammation | 3.56315253 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.50526577 |
| 6 | MP0005025_abnormal_response_to | 3.41404158 |
| 7 | MP0005671_abnormal_response_to | 3.40894517 |
| 8 | MP0003436_decreased_susceptibility_to | 3.31548526 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.21059026 |
| 10 | MP0000685_abnormal_immune_system | 3.19575353 |
| 11 | MP0002419_abnormal_innate_immunity | 2.93424930 |
| 12 | MP0001790_abnormal_immune_system | 2.85021766 |
| 13 | MP0005387_immune_system_phenotype | 2.85021766 |
| 14 | MP0002723_abnormal_immune_serum | 2.73337272 |
| 15 | MP0002006_tumorigenesis | 2.71807052 |
| 16 | MP0001800_abnormal_humoral_immune | 2.69122960 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.68688321 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.61453568 |
| 19 | MP0001819_abnormal_immune_cell | 2.36443626 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.33800087 |
| 21 | MP0004510_myositis | 2.20945408 |
| 22 | MP0004947_skin_inflammation | 2.07383784 |
| 23 | MP0001853_heart_inflammation | 2.04771317 |
| 24 | MP0009764_decreased_sensitivity_to | 2.02166238 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.99197532 |
| 26 | MP0008469_abnormal_protein_level | 1.97541694 |
| 27 | MP0002405_respiratory_system_inflammati | 1.95684987 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.93866163 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.93136808 |
| 30 | MP0003303_peritoneal_inflammation | 1.92109018 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.92102260 |
| 32 | MP0000343_altered_response_to | 1.87508964 |
| 33 | MP0000716_abnormal_immune_system | 1.79208442 |
| 34 | MP0002398_abnormal_bone_marrow | 1.76663036 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.75879332 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.73446738 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.63753288 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.61669423 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.54626859 |
| 40 | MP0003186_abnormal_redox_activity | 1.48760869 |
| 41 | MP0003448_altered_tumor_morphology | 1.47484869 |
| 42 | MP0002429_abnormal_blood_cell | 1.44866616 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.43550169 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.43093225 |
| 45 | MP0005310_abnormal_salivary_gland | 1.42392185 |
| 46 | MP0002722_abnormal_immune_system | 1.37234365 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.36595830 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.36249895 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.36249895 |
| 50 | MP0000858_altered_metastatic_potential | 1.35021898 |
| 51 | MP0003075_altered_response_to | 1.30982473 |
| 52 | MP0009278_abnormal_bone_marrow | 1.26650004 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.24131881 |
| 54 | MP0005451_abnormal_body_composition | 1.21611385 |
| 55 | MP0009763_increased_sensitivity_to | 1.16597695 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.11576715 |
| 57 | MP0002933_joint_inflammation | 1.10782784 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.07893181 |
| 59 | MP0001851_eye_inflammation | 1.06608342 |
| 60 | MP0005166_decreased_susceptibility_to | 1.04108068 |
| 61 | MP0009840_abnormal_foam_cell | 0.99948463 |
| 62 | MP0008260_abnormal_autophagy | 0.99600551 |
| 63 | MP0008004_abnormal_stomach_pH | 0.98321700 |
| 64 | MP0003828_pulmonary_edema | 0.95954678 |
| 65 | MP0002254_reproductive_system_inflammat | 0.95657790 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 0.95530003 |
| 67 | MP0005164_abnormal_response_to | 0.94409019 |
| 68 | MP0005390_skeleton_phenotype | 0.91008526 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 0.88887295 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.88812877 |
| 71 | MP0001873_stomach_inflammation | 0.88483214 |
| 72 | MP0003172_abnormal_lysosome_physiology | 0.87575726 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 0.83285976 |
| 74 | MP0000249_abnormal_blood_vessel | 0.78850172 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.78777495 |
| 76 | MP0000703_abnormal_thymus_morphology | 0.77875552 |
| 77 | MP0003866_abnormal_defecation | 0.76110920 |
| 78 | MP0002332_abnormal_exercise_endurance | 0.76099749 |
| 79 | MP0000604_amyloidosis | 0.72793555 |
| 80 | MP0003300_gastrointestinal_ulcer | 0.71181420 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.66593123 |
| 82 | MP0008874_decreased_physiological_sensi | 0.66540143 |
| 83 | MP0005023_abnormal_wound_healing | 0.66409471 |
| 84 | MP0003195_calcinosis | 0.66341418 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.63888627 |
| 86 | MP0000490_abnormal_crypts_of | 0.62770937 |
| 87 | MP0002132_abnormal_respiratory_system | 0.62540469 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.61800320 |
| 89 | MP0003690_abnormal_glial_cell | 0.61112573 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.59895667 |
| 91 | MP0001542_abnormal_bone_strength | 0.59823430 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.59302472 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.58826441 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.58616424 |
| 95 | MP0004381_abnormal_hair_follicle | 0.56550599 |
| 96 | MP0003795_abnormal_bone_structure | 0.56288868 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.54829244 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.54793798 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.54473659 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.54178836 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.54108101 |
| 102 | MP0000609_abnormal_liver_physiology | 0.53831392 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.50714914 |
| 104 | MP0003045_fibrosis | 0.49582991 |
| 105 | MP0001881_abnormal_mammary_gland | 0.48797331 |
| 106 | MP0000920_abnormal_myelination | 0.48255907 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48078311 |
| 108 | MP0005165_increased_susceptibility_to | 0.47966724 |
| 109 | MP0006054_spinal_hemorrhage | 0.47623761 |
| 110 | MP0001191_abnormal_skin_condition | 0.47233411 |
| 111 | MP0008873_increased_physiological_sensi | 0.46956973 |
| 112 | MP0001663_abnormal_digestive_system | 0.46814809 |
| 113 | MP0004883_abnormal_blood_vessel | 0.46746431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.44381598 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.91753591 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.90006456 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.33924395 |
| 5 | Myositis (HP:0100614) | 4.86819290 |
| 6 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.69863353 |
| 7 | Recurrent cutaneous fungal infections (HP:0011370) | 4.69863353 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.63859643 |
| 9 | Increased IgM level (HP:0003496) | 4.60562320 |
| 10 | Recurrent skin infections (HP:0001581) | 4.45689736 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.44491683 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.27129567 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.25057445 |
| 14 | Orchitis (HP:0100796) | 4.12168343 |
| 15 | Chronic otitis media (HP:0000389) | 3.95132358 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.82568896 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.82568896 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.82568896 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.78740844 |
| 20 | Optic neuritis (HP:0100653) | 3.78740844 |
| 21 | Basal ganglia calcification (HP:0002135) | 3.77948529 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.76050158 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.74072311 |
| 24 | Vasculitis (HP:0002633) | 3.63897154 |
| 25 | Recurrent viral infections (HP:0004429) | 3.63112337 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.58273348 |
| 27 | Stomatitis (HP:0010280) | 3.56032750 |
| 28 | Recurrent bronchitis (HP:0002837) | 3.52072009 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 3.46151706 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.43376226 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 3.39496536 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 3.25788406 |
| 33 | Thyroiditis (HP:0100646) | 3.24615998 |
| 34 | Increased IgE level (HP:0003212) | 3.13481447 |
| 35 | Loss of speech (HP:0002371) | 3.09292084 |
| 36 | Abnormality of T cell number (HP:0011839) | 3.08899554 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 3.06172761 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04568530 |
| 39 | Combined immunodeficiency (HP:0005387) | 3.03937029 |
| 40 | IgG deficiency (HP:0004315) | 3.02617422 |
| 41 | Hemoptysis (HP:0002105) | 3.01084771 |
| 42 | Pustule (HP:0200039) | 3.00764367 |
| 43 | Gingivitis (HP:0000230) | 2.96877161 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.86550854 |
| 45 | Obstructive lung disease (HP:0006536) | 2.84413495 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84413495 |
| 47 | T lymphocytopenia (HP:0005403) | 2.84172252 |
| 48 | Abnormality of T cells (HP:0002843) | 2.81230457 |
| 49 | Abnormality of the nasal mucosa (HP:0000433) | 2.79940558 |
| 50 | Leukocytosis (HP:0001974) | 2.78472367 |
| 51 | Nasal polyposis (HP:0100582) | 2.73474749 |
| 52 | Petechiae (HP:0000967) | 2.72724286 |
| 53 | Cheilitis (HP:0100825) | 2.69594439 |
| 54 | Hypoplasia of the thymus (HP:0000778) | 2.69411221 |
| 55 | Abnormality of eosinophils (HP:0001879) | 2.61150390 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.60701326 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.59704755 |
| 58 | Meningitis (HP:0001287) | 2.59475832 |
| 59 | Chronic diarrhea (HP:0002028) | 2.59364567 |
| 60 | Thrombocytosis (HP:0001894) | 2.57947859 |
| 61 | Periodontitis (HP:0000704) | 2.57221931 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.51631620 |
| 63 | Purpura (HP:0000979) | 2.50690361 |
| 64 | Prostate neoplasm (HP:0100787) | 2.50438770 |
| 65 | Cellulitis (HP:0100658) | 2.49497251 |
| 66 | Gingival bleeding (HP:0000225) | 2.48793184 |
| 67 | IgM deficiency (HP:0002850) | 2.46120136 |
| 68 | Pulmonary embolism (HP:0002204) | 2.43492894 |
| 69 | Urticaria (HP:0001025) | 2.42768593 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.42598967 |
| 71 | Increased serum ferritin (HP:0003281) | 2.37822439 |
| 72 | Arterial thrombosis (HP:0004420) | 2.37773153 |
| 73 | Dysostosis multiplex (HP:0000943) | 2.36288432 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.34902250 |
| 75 | Recurrent pneumonia (HP:0006532) | 2.34504908 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.32317165 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.32192256 |
| 78 | Episodic fever (HP:0001954) | 2.30360700 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.30358688 |
| 80 | Lymphopenia (HP:0001888) | 2.28606751 |
| 81 | Inflammation of the large intestine (HP:0002037) | 2.28320663 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.27965692 |
| 83 | Joint swelling (HP:0001386) | 2.27703514 |
| 84 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.27263404 |
| 85 | Axonal loss (HP:0003447) | 2.25547003 |
| 86 | Tetraparesis (HP:0002273) | 2.25357721 |
| 87 | Agammaglobulinemia (HP:0004432) | 2.25154491 |
| 88 | Eosinophilia (HP:0001880) | 2.21882862 |
| 89 | Chest pain (HP:0100749) | 2.18634067 |
| 90 | Epistaxis (HP:0000421) | 2.18471005 |
| 91 | Poor head control (HP:0002421) | 2.17753188 |
| 92 | Amyloidosis (HP:0011034) | 2.17611681 |
| 93 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16498923 |
| 94 | Glomerulonephritis (HP:0000099) | 2.14663015 |
| 95 | Keratoconjunctivitis (HP:0001096) | 2.13797120 |
| 96 | Keratitis (HP:0000491) | 2.12856293 |
| 97 | IgA deficiency (HP:0002720) | 2.12343358 |
| 98 | Panhypogammaglobulinemia (HP:0003139) | 2.12098873 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.11802516 |
| 100 | Porencephaly (HP:0002132) | 2.11327410 |
| 101 | Anorexia (HP:0002039) | 2.09600359 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.07979727 |
| 103 | Progressive neurologic deterioration (HP:0002344) | 2.07534704 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06959041 |
| 105 | Vertigo (HP:0002321) | 2.06219862 |
| 106 | Chronic sinusitis (HP:0011109) | 2.05609291 |
| 107 | Prolonged bleeding time (HP:0003010) | 2.05212997 |
| 108 | Joint hemorrhage (HP:0005261) | 2.04074993 |
| 109 | Disinhibition (HP:0000734) | 2.03156247 |
| 110 | Polyneuropathy (HP:0001271) | 2.02871884 |
| 111 | Abnormality of the pericardium (HP:0001697) | 2.02795337 |
| 112 | Encephalitis (HP:0002383) | 2.01172975 |
| 113 | Skin ulcer (HP:0200042) | 1.99665877 |
| 114 | Acne (HP:0001061) | 1.99651414 |
| 115 | Osteomyelitis (HP:0002754) | 1.99609196 |
| 116 | Glomerulopathy (HP:0100820) | 1.98477406 |
| 117 | Colitis (HP:0002583) | 1.98342640 |
| 118 | Arthralgia (HP:0002829) | 1.97688821 |
| 119 | Abnormality of B cell number (HP:0010975) | 1.97235675 |
| 120 | B lymphocytopenia (HP:0010976) | 1.97235675 |
| 121 | Skin rash (HP:0000988) | 1.97040402 |
| 122 | Granulocytopenia (HP:0001913) | 1.96932607 |
| 123 | Gangrene (HP:0100758) | 1.96677650 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.96486045 |
| 125 | Thick nail (HP:0001805) | 1.95134883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IKBKE | 4.45127754 |
| 2 | KIT | 4.42898857 |
| 3 | TBK1 | 4.08986303 |
| 4 | TYK2 | 3.99286855 |
| 5 | FGFR4 | 3.76727861 |
| 6 | TXK | 3.64473034 |
| 7 | JAK3 | 3.44993520 |
| 8 | MAP3K14 | 3.24745768 |
| 9 | MAP4K1 | 3.09955721 |
| 10 | BLK | 2.59378834 |
| 11 | IRAK4 | 2.50835157 |
| 12 | JAK1 | 2.45999203 |
| 13 | PBK | 2.45527614 |
| 14 | RIPK4 | 2.16885842 |
| 15 | FGFR3 | 2.03236101 |
| 16 | IKBKB | 1.89264054 |
| 17 | ZAP70 | 1.86328945 |
| 18 | ERN1 | 1.81044599 |
| 19 | MAP3K3 | 1.73545204 |
| 20 | TEC | 1.69012052 |
| 21 | NME2 | 1.67443074 |
| 22 | KDR | 1.64354488 |
| 23 | PIM2 | 1.63831732 |
| 24 | TNK2 | 1.58141511 |
| 25 | CSF1R | 1.55316486 |
| 26 | FLT3 | 1.50498992 |
| 27 | MAP3K11 | 1.47536341 |
| 28 | TAOK2 | 1.45413010 |
| 29 | BTK | 1.41525790 |
| 30 | TAOK1 | 1.37821160 |
| 31 | ADRBK2 | 1.35537825 |
| 32 | SYK | 1.34975446 |
| 33 | MST4 | 1.34410297 |
| 34 | IRAK3 | 1.33243714 |
| 35 | PRPF4B | 1.32889183 |
| 36 | LCK | 1.31963621 |
| 37 | TGFBR2 | 1.25712841 |
| 38 | TIE1 | 1.20700068 |
| 39 | CSK | 1.19170321 |
| 40 | LYN | 1.19126447 |
| 41 | TLK1 | 1.15938845 |
| 42 | HCK | 1.15517551 |
| 43 | MAP3K13 | 1.12259007 |
| 44 | MAP3K12 | 1.07110473 |
| 45 | ACVR1B | 1.02113067 |
| 46 | CHUK | 1.00784742 |
| 47 | MATK | 0.97894433 |
| 48 | DDR2 | 0.96776285 |
| 49 | JAK2 | 0.88227323 |
| 50 | MAPK11 | 0.87811339 |
| 51 | EIF2AK2 | 0.87548791 |
| 52 | BCKDK | 0.86171591 |
| 53 | HIPK2 | 0.85374278 |
| 54 | TAOK3 | 0.84345163 |
| 55 | TGFBR1 | 0.83938247 |
| 56 | NEK9 | 0.82068658 |
| 57 | EPHB1 | 0.81958461 |
| 58 | NLK | 0.81484047 |
| 59 | ITK | 0.75114839 |
| 60 | BMPR2 | 0.73056669 |
| 61 | FES | 0.69968874 |
| 62 | RPS6KA4 | 0.69724058 |
| 63 | CDC42BPA | 0.66919739 |
| 64 | PRKCD | 0.66507928 |
| 65 | PIM1 | 0.62473224 |
| 66 | ABL2 | 0.61860508 |
| 67 | MAPKAPK3 | 0.56767225 |
| 68 | IRAK1 | 0.56145295 |
| 69 | MAP2K6 | 0.55829436 |
| 70 | RPS6KA5 | 0.55436910 |
| 71 | TNIK | 0.54676086 |
| 72 | MAPK7 | 0.53812984 |
| 73 | MYLK | 0.53701843 |
| 74 | TRPM7 | 0.52431082 |
| 75 | ABL1 | 0.50820113 |
| 76 | CAMKK2 | 0.50525335 |
| 77 | EPHA3 | 0.49652131 |
| 78 | STK10 | 0.48886416 |
| 79 | EGFR | 0.47573791 |
| 80 | PRKG2 | 0.47497606 |
| 81 | TESK2 | 0.46736281 |
| 82 | FGR | 0.45921550 |
| 83 | LRRK2 | 0.44131551 |
| 84 | GRK7 | 0.42874900 |
| 85 | MUSK | 0.42369028 |
| 86 | STK4 | 0.41337536 |
| 87 | CLK1 | 0.40749154 |
| 88 | PKN1 | 0.40621123 |
| 89 | RIPK1 | 0.40378504 |
| 90 | BMPR1B | 0.40193225 |
| 91 | MST1R | 0.38378660 |
| 92 | YES1 | 0.37288599 |
| 93 | PRKCQ | 0.37111682 |
| 94 | IGF1R | 0.35780817 |
| 95 | ARAF | 0.34923504 |
| 96 | MAP2K3 | 0.34138036 |
| 97 | PRKCH | 0.33350121 |
| 98 | GRK5 | 0.32674875 |
| 99 | CAMKK1 | 0.32557779 |
| 100 | MAP3K6 | 0.31200516 |
| 101 | PTK6 | 0.30725324 |
| 102 | BMX | 0.30110110 |
| 103 | TESK1 | 0.29789139 |
| 104 | GRK6 | 0.28556810 |
| 105 | STK16 | 0.28519778 |
| 106 | MOS | 0.27977264 |
| 107 | DAPK3 | 0.25814091 |
| 108 | PRKD1 | 0.24988562 |
| 109 | MARK2 | 0.24664530 |
| 110 | PDPK1 | 0.24540832 |
| 111 | PDK1 | 0.23596102 |
| 112 | FYN | 0.23578760 |
| 113 | EIF2AK1 | 0.22155723 |
| 114 | MAP3K1 | 0.21139398 |
| 115 | MAP3K2 | 0.20714998 |
| 116 | DAPK2 | 0.20271196 |
| 117 | IRAK2 | 0.19937984 |
| 118 | MAPKAPK2 | 0.19637462 |
| 119 | INSR | 0.19499682 |
| 120 | ERBB3 | 0.18595629 |
| 121 | PIK3CG | 0.17769370 |
| 122 | MAPK4 | 0.15958241 |
| 123 | MARK3 | 0.15803498 |
| 124 | MAPK3 | 0.15662422 |
| 125 | SIK3 | 0.15326077 |
| 126 | MAP3K5 | 0.14065523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.69714702 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.26093827 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.20111365 |
| 4 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.04458644 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.99660523 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.99267016 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.86139114 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.82263568 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.80546914 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.63445954 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.61098584 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.38928009 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.35421590 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.33735635 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.14586156 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 2.11053886 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 2.09016988 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03881324 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98737708 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.92914785 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91651519 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81885924 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81317163 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79747415 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.73539919 |
| 26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.72201706 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.71603224 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70233318 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65979352 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.58635372 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56648657 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.54934051 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51938947 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41105127 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.40542493 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.31935607 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25483037 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19835560 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19282626 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.18587057 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16028126 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.10270154 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.09960015 |
| 44 | Proteasome_Homo sapiens_hsa03050 | 1.03065772 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.02139565 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.01857312 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91579743 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91498206 |
| 49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86831165 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77686231 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77500402 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75849459 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73516566 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71153113 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67033793 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66564049 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.52986012 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52465184 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52434422 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.51932234 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50732064 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48967219 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.46435594 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45569952 |
| 65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44769774 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44443144 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40482459 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40288244 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40227866 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39577227 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38940416 |
| 72 | Ribosome_Homo sapiens_hsa03010 | 0.37779606 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37352620 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34995874 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33053404 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32764679 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31568567 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31294939 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30878484 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28637227 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27805308 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25528869 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.24885388 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23250632 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22840569 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.22332972 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.21660922 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.20680126 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20548308 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18966127 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18434100 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.17886318 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17672076 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17533317 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16796464 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16267195 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16195750 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15756652 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15572158 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14640324 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.13945953 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13414592 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13242386 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.12885504 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.12292848 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.10042817 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.08833975 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08813090 |
| 109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.08781202 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.08176825 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.06837924 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.06779440 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06744673 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06585028 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05555257 |
| 116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04693053 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.04442184 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.04072849 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.03542827 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.03363225 |

